Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of VaxigripTetra in Subjects Aged 6 Months and Older in Vietnam
NCT03765437Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2019
- Primary completion
- Mar 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Vaxigrip in influenza, sponsored by Sanofi. Primary endpoints: Number of participants reporting solicited injection site reactions or systemic reactions, Unsolicited adverse events and 1 more. Started Jan 2019; status: completed.
02
Drugs
Vaxigrip
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03765437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03765437.